Divi’s Labs Q3FY22 Results: Pharma major’s profit nearly doubles to Rs 902 cr; margins grow YoY basis
Pharmaceutical major Divi’s Laboratories on Friday reported a robust October-December quarter earnings for the financial year 2021-22 (Q3FY22).
The company’s net profit almost doubled during the quarter, while revenue and margins grew year-on-year in Q3: PTI